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OBJECTIVES We sought to evaluate the ability of psychiatric anxiety-disorder history to discriminate
between women with and without angiographic coronary artery disease (CAD) in a
population with chest pain.
BACKGROUND A total of 435 women with chest pain underwent a diagnostic battery including coronary
angiography in order to improve testing guidelines for women with suspected CAD.
METHODS Women referred for coronary angiography completed questionnaires assessing prior treat-
ment history for anxiety disorder and current anxiety-related symptoms. Analyses controlled
for standard CAD risk factors.
RESULTS Forty-four women (10%) reported receiving prior treatment for an anxiety disorder. This
group acknowledged significantly higher levels of autonomic symptoms (e.g., headaches,
muscle tension [F 5 25.0, p , 0.001] and higher behavioral avoidance scores (e.g., avoidance
of open places or traveling alone by bus [F 5 4.2, p , 0.05]) at baseline testing compared
with women without prior anxiety problems. Women with an anxiety-disorder history did not
differ from those without such a history with respect to the presence of inducible ischemia or
use of nitroglycerin, although they were younger and more likely to describe both “tight” and
“sharp” chest pain symptoms and to experience back pain and episodes of nocturnal chest
pain. Logistic regression results indicated that the positive-anxiety-history group was more
likely to be free of underlying significant angiographic CAD (odds ratio 5 2.74, 95%
confidence interval 1.15 to 6.5, p 5 0.03).
CONCLUSIONS Among women with chest pain symptoms, a history of anxiety disorders is associated with a
lower probability of significant angiographic CAD. Knowledge of anxiety disorder history
may assist in the clinical evaluation of women with chest pain. (J Am Coll Cardiol 2001;37:
780–5) © 2001 by the American College of Cardiology
Among women, the presentation of angina symptoms is
neither a sensitive nor a specific marker for coronary artery
disease (CAD) (1–3). It has been suggested that the lack of
predictive value of symptoms for underlying CAD in
women is in part responsible for the less aggressive and
comparatively delayed treatment that women receive relative
to men (4–6). Although these gender-related disparities in
treatment may reduce the number of normal angiograms in
women, they may also be associated with a poorer prognosis
for the large proportion of women presenting with chest
pain or suspected myocardial ischemia that actually have
significant CAD (7,8).
Alternative physiological mechanisms, such as coronary
microvascular dysfunction (9,10), may provide an explana-
tion for chest pain and myocardial ischemia in many women.
Chest pain symptoms may also be related to noncardiac causes,
including psychological disorders (11–14). Cross-sectional
studies have demonstrated relationships between psychological
factors such as high anxiety and life stress with chest pain
symptoms in women (15–17). These associations, however,
may be interpreted to suggest that stress and anxiety contribute
to increased CAD risk (18,19), or that chest pain promotes
increased stress and anxiety resulting from symptom-related
concerns of illness or death. Evidence pertaining to the
relationship between psychological factors and an objective
measure of CAD among women with chest pain symptoms
would aid in the interpretation of these data, but we are
unaware of such findings to date.
In this study, we propose that a history of anxiety
symptoms is associated with noncardiac chest pain. Accord-
ingly, we hypothesize that women with chest pain and a
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psychiatric history of anxiety disorders are less likely to have
angiographic CAD than are those women with chest pain
symptoms and no anxiety history.
METHODS
Participant recruitment and entrance criteria. The
Women’s Ischemia Syndrome Evaluation (WISE) is a
National Heart, Lung, and Blood Institute-sponsored mul-
ticenter study assessing cardiovascular function through
state-of-the-art techniques in women referred for coronary
angiography to evaluate chest pain or suspected myocardial
ischemia (20). Participants completed a battery of symptom
and psychological questionnaires at baseline testing, along
with quantitative coronary angiography, exercise stress test-
ing and other diagnostic procedures.
Women were eligible for participation in WISE if they
were older than 18 years of age and were referred for a
coronary angiogram. Exclusion criteria included current
pregnancy, cardiomyopathy, recent myocardial infarction or
revascularization procedure (percutaneous transluminal cor-
onary angioplasty or coronary artery bypass graft), language
barrier preventing questionnaire completion and a history of
congenital heart disease, among other criteria. Recruitment
for WISE preceded psychological questionnaire develop-
ment by approximately three months. As a result, the study
population reported here represents a total of 435 women
from WISE who completed the core diagnostic protocol in
addition to the baseline psychological and anxiety question-
naires.
Psychiatric and covariate measures. Participants com-
pleted the Modified Autonomic Perception Questionnaire
(MAPQ; 21), a five-item behavioral avoidance scale, and
the Beck Depression Inventory (BDI; 22) as part of a larger
psychosocial questionnaire battery. The MAPQ contains 30
items (scores range from 0 to 120; high scores equal greater
sensitivity to sensations) that assess the patient’s perception
of bodily sensations such as muscle tension, gastrointestinal
symptoms and changes in breathing and body temperature,
among others. The avoidance scale contained five questions
(scores range from 5 to 50; higher scores equal greater
avoidance) assessing the avoidance of common situations
(traveling by bus, walking alone on busy streets, going into
crowded shops, going alone far from home, and large open
spaces) because of fear. Finally, the BDI is a widely used
21-item depression measure (scores range from 0 to 48) that
assesses both cognitive (e.g., guilt) and physical (e.g.,
changes in sleep patterns) symptoms of depression. A BDI
score of 17 is frequently used to mark the presence of
“subclinical” (i.e., not Diagnostic and Statistical Manual of
Mental Disorders [DSM-IV] (23) diagnostic for a mood
disorder) depression (22). Additional questions assessed
whether participants had ever received treatment from a
psychologist or psychiatrist for an anxiety disorder (we did
not collect data regarding the length, type, precipitating
factors or success of the treatment). Coronary artery disease
covariate measures included smoking status, total blood
cholesterol levels, hypertension status (positive/negative his-
tory), body mass index, education, functional capacity as
measured by the Duke Activity Status Index (24), age and
menopausal status.
Coronary disease severity was judged by three criteria.
First, using the quantitative angiogram results, we assigned
each participant to a group: “no CAD” (,20% maximum
stenosis), “nonobstructive CAD” (20% to 49% maximum
stenosis) or “obstructive CAD” ($50% maximum stenosis).
Second, each participant was assigned a continuous coro-
nary disease severity score based on a modified Gensini
index (25). This severity score was developed with points
assigned according to the category of severity of the stenosis
(0% to 19%, 20% to 49%, 50% to 69%, 70% to 89%, 90% to
98%, 99% to 100%) adjusting for partial (any filling of the
occluded vessel or its distal branches antegrade or retrograde
via channels other than the original lumen) and complete
collaterals. Scores were then adjusted according to lesion
location, with more proximal lesions receiving a higher
weighting factor. Finally, we used the raw maximum steno-
sis score from the participant’s angiogram as a third out-
come measure. In addition, a total of 343 (68% of the
no-anxiety-history participants and 70% of the positive-
anxiety-history group) participants also completed one or
more noninvasive tests for myocardial ischemia, including
exercise and pharmacologic stress testing with or without
echocardiographic or radionuclide imaging.
Statistical analyses. Using independent sample t tests, we
compared participants with and without a history of anxiety
disorders on measured CAD risk factors, angina symptoms
and other pain indices (e.g., headaches, back pain, etc.) and
anxiety symptoms experienced at baseline testing (i.e.,
scores on the above autonomic, avoidance and depression
scales). The predictive relationship between anxiety-
disorder history and the likelihood of angiogram-defined
CAD status was first assessed with logistic regression
methods predicting anxiety disorder history (0 5 no, 1 5
yes) on the basis of CAD and demographic covariates at
step one followed by the CAD severity categorical variable
(0 5 no CAD, 1 5 nonobstructive CAD, 2 5 obstructive
CAD) at step two. The obstructive CAD group was used as
the reference category; the resulting odds ratios represented
the odds of angiogram results falling in the no CAD group
relative to the obstructive CAD group, and nonobstructive
Abbreviations and Acronyms
BDI 5 Beck Depression Inventory
CAD 5 coronary artery disease
DSM-IV 5 Diagnostic and Statistical Manual of
Mental Disorders
HDL-C 5 high density lipoprotein cholesterol
LDL-C 5 low density lipoprotein cholesterol
MAPQ 5 Modified Autonomic Perception
Questionnaire
WISE 5 Women’s Ischemia Syndrome Evaluation
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CAD relative to obstructive CAD groups on the basis of
anxiety history. Only the first of these ratios was of interest.
In addition, because our CAD groupings could be deemed
arbitrary, and to demonstrate that relationships based on
anxiety history were not an artifact of our CAD grouping
method, we used hierarchical linear regression methods to
predict continuous CAD severity scores based on the
modified Gensini severity index and the patient’s quantita-
tive angiogram result. We forced all covariate terms into
these equations at step one of each analysis, followed by the
yes/no anxiety disorder history variable. All analyses further
included a dummy coding for participant’s knowledge of
their angiogram results (to control for the subset of partic-
ipants who completed the angiogram test prior to the
questionnaire assessment or those with a history of CAD)
and the presence/absence of ischemia.
Power analyses, calculated using a two-tailed a 5 0.05
and a sample size of 435, indicated that our probability to
detect large effects between anxiety disorder history and
CAD severity (e.g., odds ratios ,0.5) was greater than 99%,
and that power levels were smaller, but also acceptable
(0.75), for effects of moderate magnitude (e.g., odds ratios
,0.7).
RESULTS
Table 1 compares women with and without a history of
anxiety disorders across measured CAD risk factors, angina
and other physical symptoms and psychological character-
istics. Women with a history of anxiety disorders (44 of 435
[10%] participants) were younger (53.9 vs. 59.7 years of
age), more likely to smoke and had lower LDL-C blood
levels. Symptom profiles also differed between groups.
Women with a positive anxiety history indicated that their
angina episodes were longer and more likely to be relieved
by rest, and more frequently endorsed sensations of “tight-
ness” and “sharp, knife-like pain” in describing their chest
pain. This subgroup also reported more frequent episodes of
angina during sleep. Several other statistical trends were
apparent (p values ,0.10), including a pattern of seemingly
unrelated somatic complaints (back pain and headaches)
and a greater chance of experiencing angina while at rest in
the positive-anxiety-history subgroup.
Interestingly, despite prior psychological or psychiatric
treatment, the positive anxiety group expressed significantly
greater distress levels at baseline, as indicated by higher
behavioral avoidance scores and markedly greater sensitivity
to autonomic symptoms and depression levels. Patients with
a positive anxiety disorder history, therefore, were generally
much more symptomatic as a group, a pattern that held
across psychological measures, cardiac-related symptoms
and other forms of physical complaints. It is also noteworthy
that a positive anxiety-disorder history was not associated
with a lower likelihood of having inducible ischemia on
noninvasive stress testing (65% vs. 57%, p . 0.3).
Table 2 provides an unadjusted breakdown of the
anxiety-disorder history groups according to CAD severity
status, Gensini severity scores and quantitative angiogram
results. Women with a history of anxiety disorders evi-
denced significantly less severe disease across each of the
three CAD indices in comparison with women with no
history of anxiety problems (all p values , 0.05). Based on
CAD groupings, women in the positive-anxiety-history
group were more than twice as likely (54.5% vs. 25%) to
show no CAD (i.e., ,20% maximum stenosis) relative to
evidence of obstructive CAD (i.e., $50% maximum steno-
sis). In contrast, patients without an anxiety history were
almost identically distributed between the no CAD and
obstructive CAD categories (37% vs. 35%).
A positive anxiety-disorder history remained an indepen-
dent predictor of negative angiogram findings and lower
CAD severity after controlling for demographic and ath-
erosclerosis risk factors (including age, smoking status,
hypertension history, body mass index, menopause status,
HDL-C and LDL-C blood levels, education levels and
functional capacity) and a dummy coding for previous
knowledge of angiogram results. Logistic regression results
indicated that women with an anxiety disorder history were
Table 1. A Comparison of Patients With and Without an
Anxiety Disorder History on Angina and Other Physical
Symptoms, CAD Risk Factors, and Psychological
Characteristics (n 5 435)
1 Anxiety History
(n 5 44)
2 Anxiety History
(n 5 391)
Age* 53.9 (8.7) 59.7 (11.0)
% Daily angina 43.9 38.0
% Using nitroglycerin 50.0 44.6
% Angina from exertion 47.4 55.4
% Sharp, knife-like pain† 40.7 23.3
% Tightness† 66.7 58.9
% Relieved by rest† 77.8 64.7
Length of episodes (min)† 19.0 (24.2) 10.6 (13.3)
% Left arm pain 31.1 37.4
% Angina at rest 75.0 52.8
% Shortness of breath 75.0 69.6
% Angina during sleep† 56.1 39.4
% Headaches 44.2 31.7
% Migraine headaches 33.3 23.4
% Back pain† 54.5 40.1
% Current smokers* 36 16
Body mass index 29.9 (6.8) 29.6 (6.4)
HDL-C 53.8 (12.0) 54.3 (12.3)
LDL-C* 101.6 (37.6) 116.8 (39.7)
% Hypertensive 39 43
% Postmenopausal 77 83
Functional capacity (DASI) 25.1 (5.9) 24.3 (5.5)
BDI* 17.5 (9.8) 9.8 (7.4)
Avoidance scale† 13.9 (12.2) 10.4 (10.6)
MAPQ* 49.2 (15.2) 38.3 (14.7)
HRT use (%) 64.9 52.9
% Ischemic‡ 65.0 56.8
*Groups differ at p , 0.01. †Groups differ at p , .05. ‡ Based on results of exercise
stress, pharmacologic ECG, dobutamine stress echo, and radionuclide perfusion tests.
BDI 5 Beck Depression Inventory; CAD 5 coronary artery disease; DASI 5
Duke Activity Status Index; ECG 5 electrocardiogram; HDL-C 5 high density
lipoprotein cholesterol; LDL-C 5 low density lipoprotein cholesterol; MAPQ 5
Modified Autonomic Perception Questionnaire.
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nearly three times more likely to be in the lowest category of
CAD severity (i.e., ,20% maximum stenosis) relative to the
category of obstructive CAD (i.e., $50% maximum steno-
sis) compared with women without an anxiety disorder
history following covariate adjustment (odds ratio 5 2.74,
95% CI 1.15 to 6.53, p 5 0.03). Using the modified Gensini
score as a continuous measure of CAD severity, women
with an anxiety-disorder history had significantly lower
scores than women without an anxiety-disorder history after
adjustment for covariates (adjusted F 5 4.4, p 5 0.03).
Finally, the inclusion of CAD and demographic covariates
results did not affect the relationship between anxiety
history and lower disease severity in the form of quantitative
angiogram scores (adjusted F 5 5.6, p 5 0.02).
DISCUSSION
Our findings suggest that a history of anxiety disorders is
associated with a lower likelihood of angiographic CAD
among women presenting with chest pain symptoms. Al-
though previous studies have explored relationships between
psychological factors and endpoints such as angina during
exercise testing (11), the prevalence of psychological distress
among patients with angina (12) and the role of psycholog-
ical factors in silent myocardial ischemia (13,14), the present
report is the first investigation to demonstrate a clear
association between a history of anxiety disorders and an
absence of angiographic CAD in women with chest pain.
It is well known that chest pain symptoms are less reliable
markers of CAD among women (1,2), and previous publi-
cations derived from this sample proved this to be equally
true of women participating in WISE (20). Despite referral
for coronary angiography on the basis of chest pain or
suspected myocardial ischemia, previously published analy-
ses showed that a full 35% of the WISE cohort had no
evidence of CAD (i.e., maximum stenosis ,20%) based on
angiogram findings. Another 25% of this group showed
only modest evidence of nonobstructive CAD (maximum
stenosis 21% to 49%) (20). Thus, presenting symptoms were
not predictive of angiogram results in women with chest
pain.
Our results suggest that anxiety characteristics may be
one important factor contributing to false positive cases of
angina in women. In this sample, women with a positive
history of anxiety disorders expressed more severe clinical
symptoms but a substantially reduced probability of angio-
graphic CAD. Based on a categorization of the participants’
angiogram scores, members of the positive-anxiety group
were more than twice as likely to show no evidence of CAD
(i.e., ,20% maximum stenosis) than obstructive CAD
status (i.e., $50% maximum stenosis) relative to partici-
pants with no history of anxiety. However, we recognize
that our—and arguably any—categorization system for
angiogram scores could be subject to bias. For example, a
maximum stenosis of 50% (as used in our data) may seem
too low to assign to a positive CAD condition, whereas
setting the lower end of the angiogram bar higher would
result in “CAD-free” participants with at least moderate
CAD. In order to circumvent this difficulty, we further
examined anxiety relationships with objective continuous
measures of CAD: the modified Gensini severity score and
the participant’s angiogram result. We observed the same
pattern of effects across all CAD indices, however, and
because these associations proved robust to covariate adjust-
ment, it is unlikely that our findings represent a method-
ological artifact. The observation that participants with and
without a history of anxiety disorders were equally likely to
show evidence of ischemia on the basis of noninvasive
testing reinforces the potential clinical value of the psychi-
atric history data.
Limitations and topics for future research. One primary
objective of WISE is to better understand contributing
mechanisms among women with abnormal diagnostic tests
for myocardial ischemia in the absence of coronary athero-
sclerosis (20). The results presented here offer evidence
toward this goal, but several design features limit our ability
to draw causal conclusions. For one, existing evidence shows
that anxiety-disorder risk is associated with a number of
environmental, genetic and personality factors (26). As a
result, the associations observed here may be understood in
terms of the factors contributing to anxiety-disorder risk
and not anxiety-disorder history. We also did not query for
a history of depression disorders/treatment in this cohort,
and given the well-documented relationship between anxi-
ety and depressive symptoms (11–13,18), this factor may
deserve consideration in future studies. There is also the
possibility of a referral bias within the WISE sample (i.e.,
WISE participants may not represent a random sample of
women with angina, and anxiety characteristics may affect
Table 2. A Comparison of Women With and Without a History of Anxiety Disorders on Three
Indices of CAD Severity
CAD Group
(% [N])*
Continuous Severity Indices
(Mean [SD])
1 (<20%) 2 (20%–49%) 3 (>50%)
Gensini-Severity
Score†
Maximum Stenosis
Score*
2 Anxiety history 36.8 (144) 28.1 (110) 35.0 (137) 13.9 (12.8) 37.2 (35.3)
1 Anxiety history 54.5 (24) 20.4 (9) 25.0 (11) 9.0 (7.6) 25.1 (32.4)
*Groups differ p , 0.05; †Groups differ p , 0.01. CAD groups: 1 5 maximum stenosis ,20%; 2 5 maximum stenosis
20%–49%; 3 5 maximum stenosis $ 50%.
CAD 5 coronary artery disease.
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treatment-seeking behavior) that may constrain the gener-
alizability of these results. Thus, our findings should not be
misconstrued to provide direct evidence for “psychogenic”
angina.
Our observation of an association between a previous
anxiety disorder and current angiogram results also raises
questions concerning the temporal nature of this relation-
ship. We found that despite prior treatment for their anxiety
condition, the subset of women with a positive anxiety
history remained highly symptomatic on the basis of phys-
ical and psychological questionnaires (questionnaires, how-
ever, are not a substitute for an interview-based DSM-IV
diagnosis of a mood or anxiety disorder). This pattern may
suggest that an anxiety-disorder history among women with
chest pain symptoms is a marker of an enduring disposition
toward reporting more negative symptom profiles relative to
their peers. In contrast, concurrent anxiety symptoms as-
sessed at baseline testing before or after angiogram may
reflect more transient factors (e.g., concern about health or
potential test results or current life difficulties) and may
therefore offer less insight into the long-term symptom
reporting style we have shown to be linked to a reduced rate
of positive angiogram results.
A pair of additional limitations should also be mentioned
briefly. Although the relationship between anxiety-disorder
history and CAD status observed here could not be ac-
counted for on the basis of standard atherosclerosis risk
factors, our list of potential risk factors was not comprehen-
sive and alternative measures of CAD severity (e.g., electron
beam tomography) were not included. Our measure of
anxiety history was also rather global and did not allow us to
examine relationships with specific anxiety conditions. Al-
though the sample size and prevalence rate of anxiety
disorders found in our WISE population would have
limited such an examination, anxiety disorders under the
classification of the current DSM-IV include conditions
ranging from spider phobia to posttraumatic stress disorder
but do not include potentially more relevant diagnoses such
as somatization disorder or hypochondriasis. The current
findings offer no direct insight into these possibilities, but
they do suggest that the answers to these questions could be
clinically meaningful in future prospective investigations.
Furthermore, the usefulness of measuring anxiety disor-
der history variables is dependent upon factors affecting the
probability of identifying and treating such mental health
conditions in the patient’s environment. For example, lower
socioeconomic standing (although it did not affect the
results here) is associated with higher levels of psychological
distress but also with relative undertreatment (27,28). Thus,
the generalizability of our results is an important issue.
WISE is a predominantly middle-class Caucasian (80%)
cohort, which may have improved our ability to examine
questions about psychiatric treatment history. But because
relationships based on anxiety-disorder history may be
affected by differences in prevalence or diagnostic reliability,
the positive predictive value of anxiety-disorder histories
may vary among population groups.
A final caution is warranted regarding the clinical inter-
pretation of these findings. Although we observed a com-
paratively reduced likelihood of obstructive CAD among
women with chest pain who reported a history of anxiety
disorders, it is notable that a full 45% of this group
nevertheless did show angiographic evidence of moderate,
nonobstructive (i.e., maximum stenosis 20% to 49%) or
obstructive CAD (i.e., .50% stenosis). We believe this
result reinforces the need to carefully evaluate symptoms in
women irrespective of psychological history and to consider
anxiety-history variables as a topic in future investigations.
Furthermore, our results support a lower CAD likelihood in
a small (10%) subset of an exclusively female sample and do
not suggest that women as a group are less likely to have
CAD (which is the leading cause of death among both
women and men), or even that an anxious female patient is
less likely to show evidence of CAD (i.e., our results reflect
a known anxiety-disorder history, not current symptoms).
Conclusions. Our study demonstrates that the presence of
an anxiety-disorder history was associated with a signifi-
cantly lower likelihood of significant angiographic CAD
among women with angina. Determining a patient’s
anxiety-disorder history may assist the clinician in identify-
ing women with angina who are at a lower risk of underlying
CAD. Interestingly, the predictive value of anxiety-disorder
history proved to be independent of standard CAD risk
factors and the results of noninvasive stress testing. Al-
though the retrospective design leaves important questions
unanswered, these findings are among the most robust to
date in suggesting that a proportion of angina or suspected
myocardial ischemia cases among women may be associated
with psychological factors.
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